Simply enter your keyword and we will help you find what you need.

What are you looking for?

Image Alt

Call for Abstracts

Submit your abstract to present your work

Call for Abstracts .

The EA4HP-SH 2024 Scientific Committee is accepting abstracts on the continually evolving field of haematopathology.

Abstract submission is still open!

The extended submission deadline is May 30, 2024, 23:59 (CEST).
We welcome you to start preparing your abstract under one of the following categories:

Lymphoma Symposium

The 2024 EA4HP lymphoma symposium will provide in depth focus on novel mechanisms in lymphomagenesis with specific sessions dedicated to clonal lymphoid haematopoiesis, epigenetics in lymphomagenesis and lymphoproliferations associated with germline abnormalities.  These will be complemented by a session addressing new frontiers in the treatment of lymphoma and a traditional recent advances session.  The scientific program includes a mixture of Keynote and Topic Lectures supplemented by oral abstract and poster presentations.  Other highlights include the Karl Lennert Lecture, David Mason award and Meet the Professor Sessions.

Abstract submission Subject Headings

  • Clonal lymphoid haematopoiesis
  • Epigenetics in lymphomagenesis
  • Lymphoproliferations associated with germline abnormalities
  • New frontiers in the treatment of lymphoma
  • Recent Advances

Bone Marrow Symposium

The 2024 EA4HP bone marrow symposium will focus on reactive and therapy induced bone marrow changes linked to systemic infectious and non-infectious disorders, macrophage activation syndromes and hemophagocytic lymphohistiocytosis, myeloid neoplasms with evidence of the additive / cumulative effect of molecular genetic alterations that “pave the way” to a specific disease category, subcategory or entity, and lessons about the organization of the stem-, committed- and precursor-cell bone marrow populations learned from myeloid and lymphoid precursor cell neoplasms and mixed phenotype acute leukemias.

  • Reactive and therapy induced bone marrow changes
  • Organization of the stem-, committed- and precursor-cell bone marrow populations
  • Myeloid and lymphoid precursor cell neoplasms and mixed phenotype acute leukemias
  • Molecular genetics of myeloid neoplasms
  • Recent advances in myeloid neoplasms

Notification of Acceptance

The abstracts will be reviewed and selected by the scientific committee. Notifications will be sent to the authors via email.

Abstract Guidelines

Please read the essentials for abstracts carefully as abstracts not prepared correctly, will not be considered for presentation.

  • Abstract text is limited to 2,500 characters
  • Abstracts must be submitted in English
  • Please structure your abstract as follows:
    • Background
    • Principals/Methodology
    • Results
    • Conclusion
  1. Two tables and graphics can be used
  2. All abstracts must contain original work
  3. Please indicate your preferred type of presentation (oral or poster) and choose a topic
  4. Please check spelling and grammar carefully. All abstracts will be published as submitted
Get the latest updates!

Newsletter .

Subscribe to our newsletter to receive the latest news and updates about EA4HP-SH!

You can unsubscribe from the mailing list at any time.

By clicking on ‘Subscribe’, you agree to receive the newsletter with information on EA4HP-SH 2024, as well as to its analysis through individual measurement, storage and evaluation of opening rates and the click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. You can unsubscribe at any time. Please find detailed information in our privacy policy.